For the quarter ending 2026-03-28, CRL has $7,730,308K in assets. $4,741,995K in debts. $191,830K in cash and cash equivalents.
| Balance Sheets | 2026-03-28 | 2025-12-27 | 2025-09-27 | 2025-06-28 |
|---|---|---|---|---|
| Cash and cash equivalents | 191,830 | 213,770 | 207,097 | 182,824 |
| Trade receivables and contract assets, net of allowances for credit losses of 8,114 and 10,463, respectively | 700,251 | 708,856 | 734,482 | 767,569 |
| Inventories | 359,723 | 299,103 | 302,550 | 279,550 |
| Prepaid assets | 102,146 | 96,108 | 121,535 | 109,998 |
| Other current assets | 134,856 | 129,212 | 166,440 | 129,921 |
| Total current assets | 1,488,806 | 1,447,049 | 1,532,104 | 1,469,862 |
| Property, plant and equipment, net | 1,510,154 | 1,655,219 | 1,591,625 | 1,606,733 |
| Venture capital and strategic equity investments | 209,723 | 206,972 | 194,635 | 216,073 |
| Operating lease right-of-use assets, net | 317,840 | 361,415 | 374,273 | 385,756 |
| Goodwill | 3,040,032 | 2,764,253 | 2,922,281 | 2,936,265 |
| Intangible assets, net | 248,989 | 339,995 | 571,094 | 602,452 |
| Deferred tax assets | 88,599 | 67,334 | 36,907 | 46,943 |
| Other assets | 826,165 | 293,185 | 290,893 | 296,461 |
| Total assets | 7,730,308 | 7,135,422 | 7,513,812 | 7,560,545 |
| Accounts payable | 133,952 | 148,800 | 169,615 | 145,798 |
| Accrued compensation | 166,888 | 268,854 | 269,697 | 227,509 |
| Deferred revenue | 194,330 | 210,418 | 237,728 | 268,340 |
| Accrued liabilities | 372,397 | 270,085 | 228,895 | 231,567 |
| Other current liabilities | 226,137 | 222,158 | 215,953 | 207,224 |
| Total current liabilities | 1,093,704 | 1,120,315 | 1,121,888 | 1,080,438 |
| Long-term debt, net and finance leases | 2,663,133 | 2,136,360 | 2,185,453 | 2,332,374 |
| Operating lease right-of-use liabilities | 393,113 | 434,048 | 443,185 | 453,664 |
| Deferred tax liabilities | 81,399 | 95,203 | 123,007 | 109,273 |
| Other long-term liabilities | 510,646 | 138,302 | 189,462 | 185,210 |
| Total liabilities | 4,741,995 | 3,924,228 | 4,062,995 | 4,160,959 |
| Redeemable noncontrolling interests | 41,900 | 41,263 | 40,492 | 39,956 |
| Common stock, 0.01 par value 120,000 shares authorized 49,342 shares issued and 48,167 shares outstanding as of march28, 2026, and 49,217 shares issued and outstanding as of december27, 2025 | 493 | 492 | 514 | 513 |
| Additional paid-in capital | 1,967,356 | 1,947,301 | 2,015,665 | 1,992,718 |
| Retained earnings | 1,373,777 | 1,388,620 | 1,944,317 | 1,889,895 |
| Treasury stock, at cost, 1,175 and zero shares, as of march28, 2026 and december27, 2025, respectively | 209,990 | 0 | 363,431 | 363,338 |
| Accumulated other comprehensive loss | -191,042 | -171,783 | -191,616 | -166,467 |
| Total charles river laboratories international, inc. equity | 2,940,594 | 3,164,630 | 3,405,449 | 3,353,321 |
| Nonredeemable noncontrolling interest | 5,819 | 5,301 | 4,876 | 6,309 |
| Total equity | 2,946,413 | 3,169,931 | 3,410,325 | 3,359,630 |
| Total liabilities, redeemable noncontrolling interests and equity | 7,730,308 | 7,135,422 | 7,513,812 | 7,560,545 |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)